Likewise, our 8.4% PP from our aPL +ve SLE patients equals the PP of their aPL −ve patients, probably because the authors included amongst their SLE related APS also aPL +ve patients. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.